Koyfin Home > Directory > Health Care > Aimmune Therap > Long-term Debt / Equity

Aimmune Therap Long-term Debt / Equity Chart (AIMT)

Aimmune Therap annual/quarterly Long-term Debt / Equity from 2018 to 2020.
  • Aimmune Therap Long-term Debt / Equity for the quarter ending June 06, 2020 was $78m a 57.39% increase of 45m year over year
  • Aimmune Therap Long-term Debt / Equity for the last 12 months ending June 06, 2020 was $78m a 57.39% increase of 45m year over year
  • Aimmune Therap Annual Long-term Debt / Equity for 2019 was $50m a 99.96% increase of 50m from 2018
  • Aimmune Therap Annual Long-term Debt / Equity for 2018 was $0m
Other Ratios Metrics:
  • Aimmune Therap Total Debt / Capital for the quarter ending December 12, 2017 was $0m
  • Aimmune Therap Other Liabilities for the quarter ending December 12, 2018 was $3m a 9.82% increase of 0m year over year
  • Aimmune Therap Total Debt / Equity for the quarter ending December 12, 2017 was $0m
View Chart On Koyfin

Quarterly AIMT Long-term Debt / Equity Data

06/2020$78m
03/2020$59m
12/2019$50m
09/2019$33m
06/2019$24m
03/2019$19m
12/2018$0m

Annual AIMT Long-term Debt / Equity Data

2019$50m
2018$0m